Glycan modification of glioblastoma-derived extracellular vesicles enhances receptor-mediated targeting of dendritic cells
/in Dendritic Cells, Exosome, Glioblastoma, International PublicationsA Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivolumab for Resected Pancreatic Adenocarcinoma-A Proof of Antigen Discovery Feasibility in Three Patients
/in Dendritic Cells, International Publications, Pancreatic CancerHonokiol-enhanced cytotoxic T lymphocyte activity against cholangiocarcinoma cells mediated by dendritic cells pulsed with damage-associated molecular patterns
/in Dendritic Cells, Gallbladder Cancer, International PublicationsRedox modifications of cysteine-containing proteins, cell cycle arrest and translation inhibition: Involvement in vitamin C-induced breast cancer cell death
/in International Publications, MicronutrientsImmunotherapy with dendritic cells and cytokine-induced killer cells for hepatocellular carcinoma: A meta-analysis
/in Dendritic Cells, Hepatocellular Carcinoma, International PublicationsTrial watch: dendritic cell vaccination for cancer immunotherapy
/in Dendritic Cells, International PublicationsTargeting regulatory T cells by curcumin: A potential for cancer immunotherapy
/in Curcuma, International PublicationsHepatocellular carcinoma: Mechanisms of progression and immunotherapy
/in Dendritic Cells, Hepatocellular Carcinoma, International PublicationsChemoprevention of Breast Cancer With Vitamins and Micronutrients: A Concise Review
/in Breast Cancer, International Publications, Micronutrients
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer